medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (2)

Juvenile hyaline fibromatosis. Literature review

Álvarez MI, Valencia HA, Toledo BM, Mena CC, Ramírez CE
Full text How to cite this article

Language: Spanish
References: 13
Page: 139-141
PDF size: 234.48 Kb.


Key words:

Juvenile hyaline fibromatosis, gingival hypertrophy, muscular contractures.

ABSTRACT

Juvenile hyaline fibromatosis is an autosomal recessive inherited condition characterized by multiple subcutaneous nodules, gingival hypertrophy, diarrhea and recurrent infections that increases morbidity. Dermal hyaline material deposition is always found in histopathology. Currently there is no specific treatment available, but the prognosis is good.


REFERENCES

  1. Ribeiro SL, Guedes EL, Botan V, Barbosa A, Freitas EJ. “Juvenile hyaline fibromatosis: a case report and review of literature”. Acta Reumatol Port 2009; 34(1): 128-133.

  2. Kan AE, Rogers M. “Juvenile hyaline fibromatosis: an expanded clinic pathologic spectrum”. Pediatr Dermatol 1989; 6(2): 68-75.

  3. Muniz ML, Lobo AZ, Machado MC, Valente NY, Kim CA, Lourenço SV, et al. “Exuberant juvenile hyaline fibromatosis in two patients”. Pediatr Dermatol 2006; 23(5): 458-464.

  4. Larralde M, Santos-Muñoz A, Calb I, Magariños C. “Juvenile hyaline fibromatosis”. Pediatr Dermatol 2001; 18(5): 400-402.

  5. Sahn EE, Salinas CF, Sens MA, Key J, Swiger FK Jr, Holbrook KA. “Infantile systemic hyalinosis in a black infant”. Pediatr Dermatol 1994; 11(1): 52-60.

  6. Shin HT, Paller A, Hoganson G, Willner JP, Chang MW, Orlow SJ. “Infantile systemic hialinosis”. J Am Acad Dermatol 2004; 50(2 Suppl): S61- 64.

  7. Nofal A, Sanad M, Assaf M, Nofal E, Nassar A, Almokadem S. “Juvenile hyaline fibromatosis and infantile systemic hyalinosis: a unifying term and a proposed grading system”. J Am Acad Dermatol 2009; 61(4): 695- 700.

  8. Karaçal N, Gülçelik N, Yildiz K, Mungan S, Kutlu N. “Juvenile hyaline fibromatosis: a case report”. J Cutan Pathol 2005; 32(6): 438-440.

  9. Uslu H, Bal N, Guzeldemir E, Pektas ZO. “Three siblings with juvenile hyaline fibromatosis”. J Oral Pathol Med 2007; 36(2): 123-125.

  10. Vakirlis E, Kastanis A, Ioannides D. “Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris”. Ther Clin Risk Manag 2008; 4(1): 141-148.

  11. Mancini G, Oranje A, Hollander J. “In Fibromatoses, hyalinoses and stiif skin syndrome”. En: Harper J, Orange A, Prose A. Textbook Of Pediatric Dermatology. 2a ed. Vol II. Massachusetts, Blackwell, 2006: 935-956.

  12. Rahman N, Dunstan M, Teare MD, Hanks S, Edkins SJ, Hughes J, et al. “The gene for juvenile hyaline fibromatosis maps to chromosome 4q21”. Am J Hum Genet 2002; 71(4): 975-980.

  13. Ruiz-Maldonado R, Durán-McKinster C, Sáez-de-Ocariz M, Calderón- Elvir C, Yamazaki-Nakashimada MA, Orozco-Covarrubias L. “Interferon alpha-2B in juvenile hyaline fibromatosis”. Clin Exp Dermatol 2006; 31(3): 478-479.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2011;9